Align Technology | ALGN - Cash And Equivalent


Align Technology reported $1.06B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
3M USD 3.73B 1.51B Mar/2026
Align Technology USD 1.06B 35.07M Mar/2026
Becton, Dickinson and Co. USD 813M 73M Mar/2026
Bruker USD 133.4M 165.4M Mar/2026
Cardinal Health USD 3.94B 1.16B Mar/2026
Charles River Laboratories USD 191.83M 21.94M Mar/2026
Cooper Companies USD 124.9M 14.3M Dec/2025
CVS Health USD 9.54B 1.09B Mar/2026
Danaher USD 5.7B 1.09B Mar/2026
Dentsply International USD 190M 136M Mar/2026
Dexcom USD 1.12B 200.5M Mar/2026
Henry Schein USD 138M 18M Mar/2026
Idexx Laboratories USD 200.53M 20.46M Mar/2026
Insulet USD 480.4M 235.7M Mar/2026
Integra LifeSciences USD 236.81M 1.76M Mar/2026
IQVIA Holdings USD 1.95B 33M Mar/2026
Masimo USD 124.6M 187.7M Mar/2026
McKesson USD 3.98B 1.02B Mar/2026
Mettler Toledo International USD 66.89M 2.18M Dec/2025
Revvity USD 860.32M 59.54M Mar/2026
Solventum Corp USD 561M 317M Mar/2026
Stryker USD 2.88B 1.13B Mar/2026
Teleflex USD 309.41M 69.15M Mar/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Veeva Systems USD 1.9B 475.35M Mar/2026
Waters USD 462M 125.83M Mar/2026
Zimmer Biomet Holdings USD 424.2M 167.7M Mar/2026
Zoetis USD 1.94B 369M Mar/2026